You-jin Kim
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Lymph node-targeted mRNA delivery of fine-tuned peptide-nanocomplexes for SARS-CoV-2 Vaccination.
Journal: Biomaterials
Published: March 03, 2026
Cross-protective efficacy of NA-based mRNA vaccine candidates against seasonal and avian influenza viruses.
Journal: Frontiers in microbiology
Published: January 19, 2026
Immunogenicity and Protective Effects of an Ag85B Tuberculosis Subunit Vaccine Formulated with Synthetic TLR4 Agonists in BCG-Boosted Mice.
Journal: Vaccines
Published: December 11, 2025
Structure-guided design of a bivalent SARS-CoV-2 mRNA vaccine with NTD stabilizing mutations enhances broad immunity.
Journal: Frontiers in immunology
Published: October 04, 2025
Duration of vaccine-induced immunity following MMR2 vaccination in a measles and rubella-eliminated country.
Journal: International journal of epidemiology
Published: September 12, 2025
Phialomyces koreanus sp. nov., A Novel Soil Fungus from Korea.
Journal: Mycobiology
Published: August 12, 2025
AIM2 drives inflammatory cell death and monkeypox pathogenesis.
Journal: Cellular & molecular immunology
Published: March 22, 2025
Heterologous prime-boost vaccination drives stromal activation and adaptive immunity against SARS-CoV-2 variants.
Journal: Frontiers in immunology
Published: March 21, 2025
Status of Tuberculosis Vaccines Development in Clinical Trials
Journal: Jugan geon-gang gwa jilbyeong
Published: February 11, 2025
Discovery and development of a safe and efficient COVID-19 mRNA vaccine, STP2104, using a novel capping library screening method.
Journal: Frontiers in immunology
Published: February 05, 2025
Last Updated: 09/26/2026